These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2312347)

  • 21. 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium.
    Casey ML; MacDonald PC; Andersson S
    J Clin Invest; 1994 Nov; 94(5):2135-41. PubMed ID: 7962560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The "dysharmonic luteal phase" syndrome: endometrial progesterone receptor and estradiol dehydrogenase.
    Gravanis A; Zorn JR; Tanguy G; Nessmann C; Cedard L; Robel P
    Fertil Steril; 1984 Nov; 42(5):730-6. PubMed ID: 6208059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?
    Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI
    Fertil Steril; 1986 Mar; 45(3):345-52. PubMed ID: 3005052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen metabolism in normal and neoplastic endometrium.
    Gurpide E; Tseng L; Gusberg SB
    Am J Obstet Gynecol; 1977 Dec; 129(7):809-16. PubMed ID: 607809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of rat endometrial estradiol-17 beta dehydrogenase activity by estradiol and progesterone.
    Amr S; Faye JC; Bayard F; Kreitmann O
    Biol Reprod; 1980 Mar; 22(2):159-63. PubMed ID: 6929711
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of 17 beta-hydroxysteroid dehydrogenase activity in human endometrium by adrenal androgens.
    Bonney RC; Reed MJ; James VH
    J Steroid Biochem; 1983 Jan; 18(1):59-64. PubMed ID: 6223181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between oestradiol metabolism and adrenal steroids in the endometrium of postmenopausal women with and without endometrial cancer.
    Bonney RC; Scanlon MJ; Jones DL; Reed MJ; Anderson MC; James VH
    Eur J Cancer Clin Oncol; 1986 Aug; 22(8):953-61. PubMed ID: 3021469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the potency of orally administered progestins in women.
    King RJ; Whitehead MI
    Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial estradiol-17 beta-dehydrogenase activity in women wearing Cu-IUD.
    Tseng L; Dramusic V; Gurpide E
    Contraception; 1979 Mar; 19(3):247-52. PubMed ID: 455980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 17 beta-oestradiol dehydrogenase of pig endometrial cells is localized in specialized vesicles.
    Adamski J; Husen B; Marks F; Jungblut PW
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):777-82. PubMed ID: 8457206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of human endometrial estradiol dehydrogenase by progestins.
    Tseng L; Gurpide E
    Endocrinology; 1975 Oct; 97(4):825-33. PubMed ID: 172318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
    Abul-Hajj YJ
    Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of oestradiol-17 beta dehydrogenase from the progesterone-dominated mouse uterus.
    Clark BF
    J Endocrinol; 1980 Apr; 85(1):155-9. PubMed ID: 6930446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium.
    Byrjalsen I; Thormann L; Meinecke B; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Apr; 79(4):523-8. PubMed ID: 1532445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of endometrial 17 beta-hydroxysteroid dehydrogenase activity on the binding of estradiol to receptors.
    Gurpide E; Marks C
    J Clin Endocrinol Metab; 1981 Feb; 52(2):252-5. PubMed ID: 6936402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue.
    Bonney RC; Reed MJ; Davidson K; Beranek PA; James VH
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):727-39. PubMed ID: 6317235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical localization of aromatase cytochrome P-450 and estradiol dehydrogenase in the syncytiotrophoblast of the human placenta.
    Fournet-Dulguerov N; MacLusky NJ; Leranth CZ; Todd R; Mendelson CR; Simpson ER; Naftolin F
    J Clin Endocrinol Metab; 1987 Oct; 65(4):757-64. PubMed ID: 3308940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy.
    Byrjalsen I; Thormann L; Meinecke B; Riis BJ; Christiansen C
    Hum Reprod; 1992 Sep; 7(8):1042-7. PubMed ID: 1400926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy.
    King RJ; Whitehead MI; Campbell S; Minardi J
    Postgrad Med J; 1978; 54 Suppl 2():65-8. PubMed ID: 216982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of sex steroids on proliferation in normal mammary tissue.
    Söderqvist G
    Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.